In addition to analyzing patient derived next generation sequencing data, we performed FISH based confirmatory studies of Chromodomain helicase DNA-binding protein 1 (<i>CHD1</i>) loss on prostate cancer tissue microarrays. This evidence concerns the gene CHD1 and prostate carcinoma.